Study finds gabapentinoid treatment does not elevate risk of self‐harm

A population‐based case series study has found that patients taking gabapentin or pregabalin did not experience an elevated risk of self‐harm during treatment. Risk of self‐harm was elevated during pre‐ and post‐treatment periods, the investigators found. Study results were published online April 30, 2025 in The BMJ .

Publication Details

Journal
The Brown University Psychopharmacology Update
Published
2025-08-04
DOI
https://doi.org/10.1002/pu.31344
Primary Topic
Suicide and Self-Harm Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Study finds gabapentinoid treatment does not elevate risk of self‐harm

The Brown University Psychopharmacology Update
Suicide and Self-Harm Studies
article

Study finds gabapentinoid treatment does not elevate risk of self‐harm

article en

Abstract

A population‐based case series study has found that patients taking gabapentin or pregabalin did not experience an elevated risk of self‐harm during treatment. Risk of self‐harm was elevated during pre‐ and post‐treatment periods, the investigators found. Study results were published online April 30, 2025 in The BMJ .

The Brown University Psychopharmacology UpdateVol. 36(9)
Openalex Percentile: Top 73%
Suicide and Self-Harm Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Study finds gabapentinoid treatment does not elevate risk of self‐harm · The Brown University Psychopharmacology Update (2025) | TGRS Research Map | TGRS